Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleLabeled EGFr-TK irreversible inhibitor (ML03): In vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.AuthorsOrtu, Giuseppina; Ben-David, Iris; Rozen, Yulia; Freedman, Nanette M.T.; Chisin, Roland; Levitzki, Alexander; Mishani, EyalPublicationInternational Journal of Cancer, 2002, Vol 101, Issue 4, p360ISSN0020-7136Publication typeArticleDOI10.1002/ijc.10619